2026-01-13 - Analysis Report
**Financial Report for UnitedHealth Group Inc (UNH)**

### General Information

* Company Name: UnitedHealth Group Inc
* Ticker: UNH

### 1. Stock Performance Comparison

* Cumulative Return:
  - UNH: -19.27%
  - S&P 500 (VOO): 94.34%
* Divergence: -112.50 (relative divergence: 7.80%)

### 2. Stock Price Fluctuations

* Close: $340.51
* Last-Market: -$1.01
* Moving Averages:
  - 5-day SMA: $344.40
  - 20-day SMA: $335.27
  - 60-day SMA: $335.54

### 3. RSI, PPO, and Market Risk Indicator

* Market Risk Indicator (MRI): 0.80
* RSI: 61.81
* PPO: 0.40
* Recent relative divergence change: -0.90 (worsening)
* Expected Return: -274.70%

### 4. Recent News & Significant Events

* UnitedHealth stock slips on report of Medicare ‘aggressive tactics’
* Is UnitedHealth Stock (UNH) a Buy Ahead of Q4 Earnings?
* UnitedHealth Faces Renewed Scrutiny into Its Nursing Home Practices.
* UnitedHealth Stock (UNH) Under Fire for Using Aggressive Tactics to Boost Medicare Payments

### 4-2. Analyst Opinions

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.93 (~Buy)
- Opinions: 26
- Target Price (avg/high/low): 393.85 / 444.00 / 280.00

### 5. Recent Earnings Analysis

| Date | EPS | Revenue |
|------|-----|---------|
| 2025-10-28 | 2.59 | 113.16 B$ |
| 2025-08-11 | 3.76 | 111.62 B$ |
| 2025-05-07 | 6.9 | 109.58 B$ |
| 2024-11-04 | 6.56 | 100.82 B$ |
| 2025-10-28 | 6.56 | 100.82 B$ |

### 6. Financial Information

#### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $113.16B | 18.24% |
| 2025-06-30 | $111.62B | 17.93% |
| 2025-03-31 | $109.58B | 21.70% |
| 2024-12-31 | $100.81B | 21.14% |
| 2024-09-30 | $100.82B | 22.84% |

#### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $95.79B | 2.45% |
| 2025-06-30 | $94.72B | 3.60% |
| 2025-03-31 | $95.04B | 6.62% |
| 2024-12-31 | $92.66B | 5.98% |
| 2024-09-30 | $94.53B | 6.41% |

### 7. Comprehensive Analysis

UnitedHealth Group Inc (UNH) has experienced significant fluctuations in its performance, with a cumulative return of -19.27% compared to the S&P 500's 94.34%. The stock price has shown a recent decline, with a 5-day SMA of $344.40 and a 20-day SMA of $335.27. The RSI and PPO indicators suggest a mixed market risk, while the Market Risk Indicator (MRI) is 0.80. Recent news and events have raised concerns about the company's Medicare and nursing home practices. Analysts are still optimistic about the stock, with a consensus of a "Buy" and a target price of 393.85. The company's earnings have shown a decline, with an EPS of 2.59 in the latest quarter. Financial information reveals a mix of declining and increasing trends in revenue and profitability, as well as equity and ROE. Overall, the comprehensive analysis suggests caution in investing in UNH due to its volatile performance and market risk.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.